John A. Sedor
Chief Executive Officer at Sedor Pharmaceuticals LLC
Profile
John A.
Sedor is the founder of Sedor Pharmaceuticals LLC, founded in 2014, where he holds the title of Chairman & Chief Executive Officer.
He currently holds the position of Chairman & Chief Executive Officer at Nalpropion Pharmaceuticals, Inc. since 2018 and Chairman & President at Hawthorn Pharmaceuticals, Inc. Mr. Sedor's former positions include President, Chief Executive Officer & Director at Cangene Corp.
from 2012 to 2014, President & Chief Executive Officer at Sandoz, Inc. from 2001 to 2005, President, Chief Executive Officer & Director at CPEX Pharmaceuticals, Inc. from 2010 to 2011, President & Chief Executive Officer at VERION AG from 1998 to 2001, and President & Chief Executive Officer at Centeon LLC.
He was also Chairman & Chief Executive Officer at Pernix Therapeutics Holdings, Inc. from 2016 to 2019.
Mr. Sedor has also served as a Director at Velico Medical, Inc. and as a Director at Pernix Therapeutics LLC.
He held the position of President at Teva Spanish Holdco, Inc. from 2005 to 2008 and Executive Vice President at Parke, Davis & Co. LLC, Revlon Healthcare, and Rhone-Poulenc Rorer BV.
Mr. Sedor received his undergraduate degree from Duquesne University of The Holy Spirit.
John A. Sedor active positions
| Companies | Position | Start |
|---|---|---|
Sedor Pharmaceuticals LLC
 Sedor Pharmaceuticals LLC Financial ConglomeratesFinance Sedor Pharmaceuticals LLC is a pharmaceutical company that identifies, acquires, and develops acute care pharmaceutical assets for commercial licensing. The private company is based in Paoli, PA, and was founded by John A. Sedor and Barry R. Frankel. The company's lead product, Sesquient, has received FDA approval for the treatment of status epilepticus, and they are preparing to enter phase I development of their second product, Meloxicam for injection solubilized with betadex sulfobutyl ether sodium, for the potential treatment of acute post-surgical pain. Both products were licensed from Ligand Pharmaceuticals. The company is led by Chairman and CEO John Sedor and an experienced team of pharmaceutical professionals. John A. Sedor has been the CEO since incorporation. | Chief Executive Officer | 2013-12-31 |
Hawthorn Pharmaceuticals, Inc.
 Hawthorn Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Hawthorn Pharmaceuticals, Inc. develops, markets, and sells pharmaceutical products. The company is headquartered in Madison, MS. | Chairman | - |
Nalpropion Pharmaceuticals, Inc.
 Nalpropion Pharmaceuticals, Inc. Managed Health CareHealth Services Nalpropion Pharmaceuticals, Inc. operates as a biopharmaceutical company focused on the treatment of weight loss. Its products include CONTRAVE, analtrexone HCl & bupropion HCl extended release and Mysimba, a naltrexone HCl/ bupropion HCl prolonged release. The company is headquartered in Morristown, NJ. | Chief Executive Officer | 2017-12-31 |
Former positions of John A. Sedor
| Companies | Position | End |
|---|---|---|
| PERNIX THERAPEUTICS HOLDINGS INC | Chief Executive Officer | 2019-05-14 |
| CANGENE CORPORATION | Chief Executive Officer | 2014-01-31 |
CPEX Pharmaceuticals, Inc.
 CPEX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology CPEX Pharmaceuticals, Inc. is engaged in the development, licensing and commercialization of pharmaceutical products utilizing its validated drug delivery technology. Its technology enhances permeation and absorption of pharmaceutical molecules across the skin, nasal mucosa and eye through formulation development with proprietary molecules such as CPE-215. The company's first product is Testim, a gel for testosterone replacement therapy, which is a formulation of its technology with testosterone. Testim is licensed to Auxilium Pharmaceuticals, Inc., which is currently marketing it in the United States, Europe and other countries. Its other product is Nasulin, which is an intranasal formulation of insulin being developed to treat hyperglycemia in patients suffering from Type 1 and Type 2 diabetes. The company was founded on September 28, 2007 and is headquartered in Exeter, NH. | Chief Executive Officer | 2010-12-31 |
Teva Spanish Holdco, Inc.
 Teva Spanish Holdco, Inc. Pharmaceuticals: MajorHealth Technology Teva Spanish Holdco, Inc. manufactures, markets, and distributes pharmaceutical products. It specializes in offering treatment for cardiovascular, gastrointestinal, infectious, and neurological diseases. The firm was founded in 1974, and is headquartered in Exeter, NH. | President | 2007-12-31 |
Sandoz, Inc.
 Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Sandoz, Inc. develops, manufactures and distributes generic pharmaceutical products. The firm focuses on therapeutic drug categories such as anti-infective, central nervous system disorder treatments, cardiovascular medicines, gastrointestinal agent, oncology therapies, and respiratory therapies. The company was founded in 1946 and is headquartered in Princeton, NJ. | Chief Executive Officer | 2005-04-30 |
Training of John A. Sedor
| Duquesne University of The Holy Spirit | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 15 |
|---|---|
Teva Spanish Holdco, Inc.
Teva Spanish Holdco, Inc. Pharmaceuticals: MajorHealth Technology Teva Spanish Holdco, Inc. manufactures, markets, and distributes pharmaceutical products. It specializes in offering treatment for cardiovascular, gastrointestinal, infectious, and neurological diseases. The firm was founded in 1974, and is headquartered in Exeter, NH. | Health Technology |
Cangene Corp.
 Cangene Corp. Pharmaceuticals: MajorHealth Technology Cangene Corp. developed, manufactured and sold biopharmaceutical drugs. The company was founded on February 22, 1984 and was headquartered in Winnipeg, Canada. | Health Technology |
Sandoz, Inc.
Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Sandoz, Inc. develops, manufactures and distributes generic pharmaceutical products. The firm focuses on therapeutic drug categories such as anti-infective, central nervous system disorder treatments, cardiovascular medicines, gastrointestinal agent, oncology therapies, and respiratory therapies. The company was founded in 1946 and is headquartered in Princeton, NJ. | Health Technology |
CPEX Pharmaceuticals, Inc.
CPEX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology CPEX Pharmaceuticals, Inc. is engaged in the development, licensing and commercialization of pharmaceutical products utilizing its validated drug delivery technology. Its technology enhances permeation and absorption of pharmaceutical molecules across the skin, nasal mucosa and eye through formulation development with proprietary molecules such as CPE-215. The company's first product is Testim, a gel for testosterone replacement therapy, which is a formulation of its technology with testosterone. Testim is licensed to Auxilium Pharmaceuticals, Inc., which is currently marketing it in the United States, Europe and other countries. Its other product is Nasulin, which is an intranasal formulation of insulin being developed to treat hyperglycemia in patients suffering from Type 1 and Type 2 diabetes. The company was founded on September 28, 2007 and is headquartered in Exeter, NH. | Health Technology |
Velico Medical, Inc.
 Velico Medical, Inc. Electronic Equipment/InstrumentsElectronic Technology Velico Medical, Inc. operates as a pre-clinical medical technology company that develops and commercializes products for use in preparing and storing platelets and plasma, including a companion instrument and disposable product for spray drying plasma. Its products include FrontlineODP (on demand Plasma) and FrontlinePPS (Platelet Protection System). The company was founded by Robert W. Middleton and Cabot G. L. Henderson in 1991 and is headquartered in Beverly, MA. | Electronic Technology |
VERION AG
 VERION AG Financial ConglomeratesFinance VERION AG operates as an investment holding company, which engages in the acquisition, management, and sale of shareholdings in companies. It also engages in other activities related to its business operations. The company was founded in 2005 and is headquartered in Munich, Germany | Finance |
| Centeon LLC | |
| Parke, Davis & Co. LLC | |
Hawthorn Pharmaceuticals, Inc.
Hawthorn Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Hawthorn Pharmaceuticals, Inc. develops, markets, and sells pharmaceutical products. The company is headquartered in Madison, MS. | Health Technology |
Pernix Therapeutics LLC
 Pernix Therapeutics LLC Drugstore ChainsRetail Trade Pernix Therapeutics LLC is engaged in the development, marketing, and sale of generic pharmaceutical products. The company was founded on October 2, 2009 and is headquartered in Gonzales, LA. | Retail Trade |
| Revlon Healthcare | |
| Rhone-Poulenc Rorer BV | |
Pernix Therapeutics Holdings, Inc.
 Pernix Therapeutics Holdings, Inc. Pharmaceuticals: MajorHealth Technology Pernix Therapeutics Holdings, Inc. engages in the research, development, and manufacture of biopharmaceutical products. It focuses on therapeutics for diseases on central nervous system, neurology, pain, and psychiatry. Its products include treatment of migraine pain and inflammation, insomnia, and depressive disorder. It distributes products through the following brands: Treximet, Silenor, and Zohydro ER with BeadTek. The company was founded in 1996 and is headquartered in Morristown, NJ. | Health Technology |
Sedor Pharmaceuticals LLC
Sedor Pharmaceuticals LLC Financial ConglomeratesFinance Sedor Pharmaceuticals LLC is a pharmaceutical company that identifies, acquires, and develops acute care pharmaceutical assets for commercial licensing. The private company is based in Paoli, PA, and was founded by John A. Sedor and Barry R. Frankel. The company's lead product, Sesquient, has received FDA approval for the treatment of status epilepticus, and they are preparing to enter phase I development of their second product, Meloxicam for injection solubilized with betadex sulfobutyl ether sodium, for the potential treatment of acute post-surgical pain. Both products were licensed from Ligand Pharmaceuticals. The company is led by Chairman and CEO John Sedor and an experienced team of pharmaceutical professionals. John A. Sedor has been the CEO since incorporation. | Finance |
Nalpropion Pharmaceuticals, Inc.
Nalpropion Pharmaceuticals, Inc. Managed Health CareHealth Services Nalpropion Pharmaceuticals, Inc. operates as a biopharmaceutical company focused on the treatment of weight loss. Its products include CONTRAVE, analtrexone HCl & bupropion HCl extended release and Mysimba, a naltrexone HCl/ bupropion HCl prolonged release. The company is headquartered in Morristown, NJ. | Health Services |
- Stock Market
- Insiders
- John A. Sedor
